KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q4 2021 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA) Q4 2021 Earnings Conference Call March 29, 2022 08:00 ET Company Participants Jill Steier - Executive Director, Investor Relations and Corporate Communications Mark Iwicki - Chairman and Chief Executive Officer Todd Bazemore - President and Chief Operating Officer Kim Brazzell - Head, R&D and Chief Medical Officer Mary Reumuth - Chief Financial Officer Darius Kharabi - Chief Business Officer Conference Call Participants Andreas Argyrides - Wedbush Chris Neyor - JPMorgan Franc Brisebois - Oppenheimer Chris Howerton - Jefferies Yi Chen - H.C. Wainwright Tim Chiang - Northland Securities Presentation Operator Good morning and welcome to Kala Pharmaceuticals Conference Call to review its Fourth Quarter and Full Year 2021 Financial Results. [Operator Instructions] As a reminder, this call is being recorded. I would like to turn the call over to Jill Steier, Executive Director, Investor Relations and Corporate Communications for Kala Pharmaceuticals. Please proceed. Jill Steier Thank
For further details see:
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q4 2021 Results - Earnings Call Transcript